Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1'-sulfoöxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'-hydroxysafrole in mouse liver.

The role of sulfation of 1'-hydroxysafrole in the formation of hepatic macromolecular adducts and in hepatic tumor formation in mice given 1'-hydroxysafrole was investigated by the use of: (a) mice treated with the specific sulfotransferase inhibitor pentachlorophenol; and (b) brachymorphic mice, which are characterized by a deficiency in the hepatic synthesis of 3'-phosphoadenosine 5'-phosphosulfate. Cytosolic sulfotransferase activity for 1'-hydroxysafrole in both mouse and rat liver was significantly inhibited by 10 microM pentachlorophenol, usually by greater than 90%. Prior administration of nontoxic amounts of pentachlorophenol, either in the diet of adult female CD-1 mice or by i.p. injection of 12-day-old male C57BL/6 X C3H F1 (hereafter called B6C3F1) mice, resulted in an 85% decrease in the level of adducts formed from 1'-hydroxysafrole in hepatic DNA and RNA as compared to those of non-pentachlorophenol-treated animals. Likewise, the chronic administration of a nontoxic level of pentachlorophenol in the diet of adult female CD-1 mice strongly inhibited hepatic tumor induction by long-term dietary administration of either safrole or 1'-hydroxysafrole. Initiation of hepatic tumors by a single i.p. injection of 1'-hydroxysafrole to 12-day-old male B6C3F1 mice was strongly inhibited by prior treatment with pentachlorophenol. Under these conditions, the hepatocarcinogenicity of diethylnitrosamine was not inhibited by pentachlorophenol. Supplementation with adenosine triphosphate and sulfate of hepatic cytosols from adult female or 12-day-old brachymorphic progeny of a B6C3 background outbred to B6C3F1 mice (B6C3F2), of either sex, resulted in 5- to 10-fold less binding of 1'-hydroxysafrole to added RNA than when cytosols from phenotypically normal B6C3F2 mice were used. On administration of [3H]-1'-hydroxysafrole to adult female or 12-day-old brachymorphic B6C3F2 mice of either sex, the levels of hepatic DNA and RNA adducts were 7- to 12-fold lower than those obtained in phenotypically normal B6C3F2 mice of the same age and sex. Brachymorphic mice were also much less responsive than their phenotypically normal littermates to the induction of liver tumors by 1'-hydroxysafrole; lower incidences were observed both when the carcinogen was fed chronically to adult females and when it was administered to males only prior to weaning. Thus, all of these data strongly support the conclusion that 1'-sulfoöxysafrole is the major ultimate electrophilic and tumor-initiating metabolite of 1'-hydroxysafrole.

[1]  G. Mulder,et al.  Prevention of the hepatotoxic action of N-hydroxy-2-acetylaminofluorene in the rat by inhibition of N-O-sulfation by pentachlorophenol. , 1981, Life sciences.

[2]  K. Sugahara,et al.  Defect in 3'-phosphoadenosine 5'-phosphosulfate formation in brachymorphic mice. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Miller,et al.  The reactivity and carcinogenicity of aflatoxin B1-2,3-dichloride, a model for the putative 2,3-oxide metabolite of aflatoxin B1. , 1975, Cancer research.

[4]  E C Miller,et al.  Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. , 1983, Cancer research.

[5]  Douglas A. Wolfe,et al.  Nonparametric Statistical Methods , 1973 .

[6]  I. Jakobson,et al.  Metabolism of 14 C-pentachlorophenol in the mouse. , 2009, Acta pharmacologica et toxicologica.

[7]  G. Mulder,et al.  Inhibition of sulfate conjugation of N-hydroxy-2-acetylaminofluorene in isolated perfused rat liver and in the rat in vivo by pentachlorophenol and low sulfate. , 1980, Cancer research.

[8]  J. Miller,et al.  1'-Hydroxysafrole, a proximate carcinogenic metabolite of safrole in the rat and mouse. , 1973, Cancer research.

[9]  K. Sugahara,et al.  Defect in 3'-phosphoadenosine 5'-phosphosulfate synthesis in brachymorphic mice. II. Tissue distribution of the defect. , 1982, Archives of biochemistry and biophysics.

[10]  A. Tannenbaum,et al.  The influence of the degree of caloric restriction on the formation of skin tumors and hepatomas in mice. , 1949, Cancer research.

[11]  F. Homburger,et al.  Toxic and possible carcinogenic effects of 4-allyl-1,2-methylenedioxybenzene (Safrole) in rats on deficient diets. , 1961, Medicina experimentalis : International journal of experimental medicine.

[12]  J. Miller,et al.  N2 atom of guanine and N6 atom of adenine residues as sites for covalent binding of metabolically activated 1'-hydroxysafrole to mouse liver DNA in vivo. , 1981, Cancer research.

[13]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[14]  E C Miller,et al.  The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes. , 1981, Biochimica et biophysica acta.

[15]  G. Mulder,et al.  Phenol sulphotransferase and uridine diphosphate glucuronyltransferase from rat liver in vivo and vitro. 2,6-Dichloro-4-nitrophenol as selective inhibitor of sulphation. , 1977, The Biochemical journal.

[16]  K. Sugahara,et al.  Defect in 3'-phosphoadenosine 5'-phosphosulfate synthesis in brachymorphic mice. II. Tissue distribution of the defect. , 1982 .

[17]  N. Mantel,et al.  Carcinogenicity testing of selected food additives by parenteral administration to infant Swiss mice. , 1970, Toxicology and applied pharmacology.

[18]  J. Miller,et al.  Reactivity in vivo of the Carcinogen N-Hydroxy-2-acetylaminofluorene: Increase by Sulfate Ion , 1970, Science.

[19]  G. Goerz,et al.  Induction of the hepatic microsomal and nuclear cytochrome P-450 system by hexachlorobenzene, pentachlorophenol and trichlorophenol. , 1979, Chemico-biological interactions.

[20]  E C Miller,et al.  Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules , 1981, Cancer.

[21]  C. King,et al.  Enzyme-Catalyzed Reactions of the Carcinogen N-Hydroxy-2-fluorenylacetamide with Nucleic Acid , 1968, Science.

[22]  J. V. Bradley Distribution-Free Statistical Tests , 1968 .

[23]  S. Singer Enzymatic sulfation of steroids. VI. A simple, rapid method for routine enzymatic preparation of 3'-phosphoadenosine-5'-phosphosulfate. , 1979, Analytical biochemistry.

[24]  E. Guenther The essential oils , 1972 .

[25]  C. Irving,et al.  Isolation of deoxyribonucleic acid and ribosomal ribonucleic acid from rat liver. , 1968, Biochimica et biophysica acta.

[26]  E C Miller,et al.  Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1'-hydroxyestragole in the mouse and mutagenicity of 1'-acetoxyestragole in bacteria. , 1976, Journal of the National Cancer Institute.

[27]  G. Williams,et al.  On the sulfate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat. , 1972, Cancer research.

[28]  G. Martin,et al.  Undersulfated chondroitin sulfate in the cartilage matrix of brachymorphic mice. , 1976, Developmental biology.

[29]  C. Irving,et al.  Lack of N-hydroxy-2-acetylaminofluorene sulfotransferase activity in the mammary gland and Zymbal's gland of the rat. , 1971, Cancer research.

[30]  A. Poland,et al.  Effect of the brachymorphic trait in mice on xenobiotic sulfate ester formation. , 1983, Biochemical pharmacology.

[31]  F. Homburger,et al.  Sex effect on hepatic pathology from deficient diet and safrole in rats. , 1962, Archives of pathology.

[32]  A. Y. Leung,et al.  Encyclopedia of Common Natural Ingredients: Used in Food, Drugs, and Cosmetics , 1980 .

[33]  J. Miller,et al.  THE CARCINOGENIC ACTIVITIES OF N-HYDROXY-2-ACETYLAMINOFLUORENE AND ITS METAL CHELATES AS A FUNCTION OF RETENTION AT THE INJECTION SITE. , 1965, Cancer research.

[34]  A. A. Nelson,et al.  Liver tumours produced in rats by feeding safrole. , 1963 .

[35]  J. Miller,et al.  Carcinogenic and mutagenic activities of safrole, 1'-hydroxysafrole, and some known or possible metabolites. , 1977, Cancer research.

[36]  E C Miller,et al.  Structures of the DNA adducts formed in mouse liver after administration of the proximate hepatocarcinogen 1'-hydroxyestragole. , 1981, Cancer research.

[37]  J J Gart,et al.  Bioassay of pesticides and industrial chemicals for tumorigenicity in mice: a preliminary note. , 1969, Journal of the National Cancer Institute.

[38]  N. Schwartz,et al.  Defective PAPS-synthesis in epiphyseal cartilage from brachymorphic mice. , 1978, Biochemical and biophysical research communications.

[39]  J. Miller,et al.  The metabolic activation of the carcinogen 1'-hydroxysafrole in vivo and in vitro and the electrophilic reactivities of possible ultimate carcinogens. , 1976, Cancer research.

[40]  J. Goldstein,et al.  Effects of pentachlorophenol on hepatic drug-metabolizing enzymes and porphyria related to contamination with chlorinated dibenzo-p-dioxins and dibenzofurans. , 1977, Biochemical pharmacology.